The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study

MLA

Andreas Charidimou, et al. “The Boston Criteria Version 2.0 for Cerebral Amyloid Angiopathy: A Multicentre, Retrospective, MRI-Neuropathology Diagnostic Accuracy Study.” The Lancet. Neurology, vol. 21, no. 8, Dec. 2021. EBSCOhost, https://doi.org/10.1016/S1474-4422(22)00208-3.

APA

Andreas Charidimou, Gregoire Boulouis, Matthew P Frosch, Jean-Claude Baron, Marco Pasi, Jean Francois Albucher, Gargi Banerjee, Carmen Barbato, Fabrice Bonneville, Sebastian Brandner, Lionel Calviere, François Caparros, Barbara Casolla, Charlotte Cordonnier, Marie-Bernadette Delisle, Vincent Deramecourt, Martin Dichgans, Elif Gokcal, Jochen Herms, … Steven M Greenberg. (2021). The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. The Lancet. Neurology, 21(8). https://doi.org/10.1016/S1474-4422(22)00208-3

Chicago

Andreas Charidimou, Gregoire Boulouis, Matthew P Frosch, Jean-Claude Baron, Marco Pasi, Jean Francois Albucher, Gargi Banerjee, et al. 2021. “The Boston Criteria Version 2.0 for Cerebral Amyloid Angiopathy: A Multicentre, Retrospective, MRI-Neuropathology Diagnostic Accuracy Study.” The Lancet. Neurology 21 (8). doi:10.1016/S1474-4422(22)00208-3.